A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

NCT07412353 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: SYH2085
DRUG: Placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.